ERIN RUSE: Open Payments
NPI 1275653461 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 103 payments from 23 companies in 2025. Trend: 2023 $1,317 · 2024 $3,368 · 2025 $2,459
Food & beverage: $2,459
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 29 | $483 |
| Abbott Laboratories | 7 | $314 |
| Insulet Corporation | 15 | $310 |
| BETA BIONICS, INC. | 10 | $273 |
| Tandem Diabetes Care, Inc. | 3 | $161 |
| Amgen Inc. | 5 | $105 |
| Lilly USA, LLC | 5 | $104 |
| Novo Nordisk Inc | 4 | $95 |
| Dexcom, Inc. | 2 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
Products named: MINIMED 780G, Omnipod, FREESTYLE LIBRE 3, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, Dexcom G6 Transmitter, Kerendia, TZIELD.
Industry payments across SC — which companies pay providers there.
